The NVPO Unmet Needs Program: Looking Back and Moving Forward Ben Schwartz National Vaccine Program Office National Vaccine Advisory Committee Meeting,

Slides:



Advertisements
Similar presentations
CDCs 21 Goals. CDC Strategic Imperatives 1. Health impact focus: Align CDCs people, strategies, goals, investments & performance to maximize our impact.
Advertisements

Insert name Contact information What is an Advanced Practice Center? Each Advanced Practice Center (APC) is a local health departmentone that has been.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDAs website for reference purposes only. It.
Pandemic Influenza Vaccine Prioritization: Rationale and Process Pandemic Influenza Vaccine: Doses Administered and Safety Training Conference Tom Shimabukuro,
Logic Models and Evaluation Glen W. White 1 Jamie Simpson 2 1 University of Kansas, Research and Training Center on Independent Living 2 Kansas Department.
Brian A. Harris-Kojetin, Ph.D. Statistical and Science Policy
The NVPO Unmet Needs Program: FY 2006 Update Ben Schwartz National Vaccine Program Office National Vaccine Advisory Committee Meeting, June 2006.
Transition from Part C to Part B in Louisiana (Session # S & 115)
London November 9th1 The Independent Assessment Committee London November 9th, 2006.
Indian Affairs, January 9, 2013 introducing BUDGET FORMULATION FY 2015.
U.S. Pandemic Influenza Preparedness and Response: Planning and Activities “The pandemic influenza clock is ticking. We just don’t know what time it is.”
CADTH Therapeutic Reviews
Sustaining Community Based Programs CYFAR Conference Boston, 2005.
1. 2 The Public Health Agency of Canada Pandemic Influenza Preparedness: An Overview Dr. Paul Gully Deputy Chief Public Health Officer Ottawa, 19 January.
1 Prioritization of Vaccine Targets for Development CDR Angela Shen National Vaccine Program Office June 2, 2010 NVAC.
OPTIONS AND REQUIREMENTS FOR ENGAGEMENT OF CIVIL SOCIETY IN GEF PROJECTS AND PROGRAMMES presented by Faizal Parish Regional/Central Focal Point GEF NGO.
HealthSanté CanadaCanada Influenza Prevention and Control in Canada Arlene King, MD, MHSc, FRCPC Director, Immunization and Respiratory Infections Division,
The National Vaccine Plan Process - Update October 22, 2007 Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services.
Creating a New Vision for Kentucky’s Youth Kentucky Youth Policy Assessment How can we Improve Services for Kentucky’s Youth? September 2005.
ATP NVAC PIWG Report Pandemic Influenza Antiviral Strategies and Priority Groups Andrew T. Pavia M.D. University of Utah.
Overview of ARS National Programs Steven Kappes Deputy Administrator Animal Production & Protection National Program Staff Agricultural Research Service.
Adult Immunization at CDC Gina T. Mootrey, DO, MPH NVAC, October 22, 2007.
Evaluation Assists with allocating resources what is working how things can work better.
United We Ride: Where are we Going? December 11, 2013 Rik Opstelten United We Ride Program Analyst.
Performance Assessment Assessment of Organizational Excellence NSF Advisory Committee for Business and Operations May 5-6, 2005.
Fiscal Year (FY) 2015 National Training and Technical Assistance Cooperative Agreements (NCA) Funding Opportunity Announcement (FOA) HRSA Objective.
Creating a Sport Tourism Action Plan Huntsville September 24, 2005.
Strategic Issues in Vaccine Research (SIVR) Program Update, 2007 Ben Schwartz, NVPO NVAC June 2007.
U.S. Pandemic Influenza Preparedness and Response: Update & Progress Report “The pandemic influenza clock is ticking. We just don’t know what time it is.”
A Potential Influenza Pandemic: Possible Macroeconomic Effects and Policy Issues Julie Somers Congressional Budget Office Prepared for the Ninth Annual.
America Responds: An HHS 2009-H1N1 Retrospective to Advance All Hazards Preparedness Discussion with the National Vaccine Advisory Committee June 3, 2010.
Care Management 101 Governor's Office of Health Care Reform October 28, 2010 Cathy Gorski, RN, BS, CCM.
Age & Disabilities Odyssey Conference Tuesday, June 21, 2011.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
National Vaccine Advisory Committee Report from the Chair Gus Birkhead, MD, MPH NVAC Chair June 2, 2010.
National Vaccine Advisory Committee Report from the Chair Gus Birkhead, MD, MPH NVAC Chair February 3, 2010.
(Slide 1 of 22) Response to the National Vaccine Advisory Committee Recommendations on the Immunization Safety Office Scientific Agenda Frank DeStefano,
Strategies to Consider to Improve ACCV Effectiveness Presentation to ACCV Vito Caserta M.D., M.P.H. Vincent Matanoski, J.D. December 5,
NVAC Influenza Vaccine Recommendations and Strategies Subgroup Members: Jerome Klein (Chair), Jeff Davis, Jon Abramson, Carolyn Bridges, Nancy Cox, Ben.
Using Logic Models in Program Planning and Grant Proposals The Covenant Foundation.
Creating an Integrated Framework for Reducing Disparities in Health Care Quality Francis D. Chesley, Jr., MD Director Office of Extramural Research, Education.
1 Nanoscale Materials Stewardship Program Environmental Summit May 20, 2008 Jim Alwood Chemical Control Division Office of Pollution Prevention and Toxics.
Budget Formulation 2017/2018 A review of the 2017 process and the 2018 process. Office of Budget and Performance Management November 2015.
OFFICE OF VACCINES RESEARCH AND REVIEW Center for Biologics Evaluation and Research Michael J. Brennan, Ph.D. Associate Director for Research OVRR Site.
NVAC Influenza Working Group Vaccine Research, Development and Production.
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
CBER Research: OBRR Office Site Visit Kathryn M. Carbone, MD Associate Director of Research CBER/FDA.
Partnership Health: Evaluation and possibilities for an adapted structure Agenda item 11 Madhavi Bajekal, ONS (UK) PH coordinator Directors of Social Statistics.
Public Health Options for Implementing Vaccine Recommendations: A Framework for State Decision Making Donald Williamson, M.D. National Vaccine Advisory.
Adult Immunization: Goals, Challenges, and a role for the National Vaccine Advisory Committee October 22, 2007 Raymond A. Strikas, MD National Vaccine.
Rome Donors Meeting September 7th1 Consultation of AMC concept with key stakeholders Rome Donors Meeting September 7 th, 2006.
The National Vaccine Plan Update: Recent Activities and Next Steps Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human.
THE NATIONAL VACCINE PROGRAM OFFICE NATIONAL ADULT IMMUNIZATION PLAN OVERVIEW.
HHS Secretary’s Advisory Committee on Blood Safety and Availability Summary of November 2010 ACBSA for FDA’s BPAC December 2010 CDR Richard Henry, USPHS.
NVAC Influenza Working Group: Preliminary Report Charles Helms, M.D., Ph.D. June 1, 2004.
OFFICE OF VACCINES RESEARCH AND REVIEW Center for Biologics Evaluation and Research Michael J. Brennan, Ph.D. Associate Director for Research OVRR Site.
BIMILACI 2007 Partners for Quality Infrastructure: The FIDIC Vision Washington, May 10, 2007 Dr. Jorge Díaz Padilla FIDIC President.
CU Development Grants 2016 Information Session 482 MacOdrum Library June 2 nd, 2016.
Presented by Cary Bloyd, U.S. Department of Energy Report to the EWG/EGEEC February
CBP Biennial Strategy Review System
DOE Nuclear Safety Research and Development Program
Overview – Guide to Developing Safety Improvement Plan
Research Program Strategic Plan
Overview – Guide to Developing Safety Improvement Plan
The Ontario Experience National Immunization Conference
CBP Biennial Strategy Review System ~Meetings Detail~ DRAFT August 29, /6/2018 DRAFT.
CBP Biennial Strategy Review System
Implementation Guide for Linking Adults to Opportunity
S-STEM (NSF ) NSF Scholarships for Science, Technology, Engineering, & Mathematics Information Materials 6 Welcome! This is the seventh in a series.
Updating the National Vaccine Plan: A roadmap for the next decade A National, not Federal, Plan December 11, 2009.
Presentation transcript:

The NVPO Unmet Needs Program: Looking Back and Moving Forward Ben Schwartz National Vaccine Program Office National Vaccine Advisory Committee Meeting, September 2006

Outline Program overview Evaluation of outcomes, FY 2006 priorities and funded projects NVAC/Agency/NVPO Working Group on the Unmet Needs Program FY 2007 Working Group suggested priority categories Next steps

NVPO Unmet Needs Program Provides support for high priority vaccine and immunization projects Based on National Vaccine Plan & current HHS, NVPO, and NVAC priorities “Seed money” and “catalytic funding” Addresses new and emerging issues that fall outside regular agency funding cycle Applicants include scientists/project officers from HHS agencies, DoD, and USAID

NVPO Unmet Needs Program Projects funded for a maximum of 2-years Intramural and extramural Research and conferences Domestic and international $4 to $5 M provided annually for new and continuation projects Funding decisions made competitively based on a defined review process

Goals of the National Vaccine Plan Goal 1: Develop new and improved vaccines Goal 2: Ensure the optimal safety and effectiveness of vaccines and immunization Goal 3: Better educate the public and members of the health professions on the benefits and risks of immunization Goal 4: Achieve better use of existing vaccines to prevent disease, disability, and death

Evaluation of Unmet Needs Projects Funded in Survey of project PIs 114/178 responses (64%) Objective outcomes 68% peer-reviewed publications 38% continued project with other funding; 37% developed follow-up project 20% retained staff after project 67% of projects provided training for fellows/post-docs 42% extramural collaboration (14% interagency collab.)

Evaluation of Unmet Needs Projects Funded in Subjective outcomes 98% fully/partially successful (met all/some objectives) 40% enhanced collaboration between agencies 90% unlikely to have been funded without this program Major impacts Improved assessment/safety of cell substrates Addressed specific vaccine safety concerns Contributed to vaccine development Contributed to new vaccine recommendations Assessed impacts of new vaccines

Evaluation of Unmet Needs Projects Funded in Program concerns Several projects were funded for continuing activities based on new proposals submitted after funding for a prior project period ended Some projects fall within priority categories but do not address highest priority near term issues affecting HHS and NVPO One funded project was not done because the PI left the agency

FY 2006 Unmet Needs Priority Categories Adolescent and adult vaccination New and future vaccines Pandemic and annual influenza Vaccine safety Vaccine supply and financing Economic analysis of vaccines and vaccination programs

FY06 Unmet Needs- Funded Projects Priority category Number of Projects FundedSubmitted (rate) Adol & adult vaccination 110 (10%) New & future vaccines 14*48 (29%) Pandemic & annual flu 7**21 (33%) Vaccine safety 311 (27%) Vaccine supply & finance 0 1 (0%) Vaccine economic studies 0 8 (0%) TOTAL25 93 (25%)*** * 6 projects on New Vaccines (2 adolescent); 8 projects on Future Vaccines ** 4 projects funded with HHS pandemic influenza resources *** Some projects address multiple priority categories

Unmet Needs Program: Taking Stock and Moving Forward Important issues for HHS and NVAC – such as vaccine financing – are not being addressed by funded projects Current priority categories are broad and funded projects may not be closely linked with current HHS and NVAC issues The approach to selecting projects for funding can be improved

NVAC/Agency/NVPO Working Group on the Unmet Needs Program 3 representatives from each group NVAC: Dekker, Freed, Humiston Agency: Baylor, Curlin, Schuchat NVPO: Bart, Gellin, Schwartz Working Group objectives Improve the program focus Propose FY07 priority categories Suggest changes to improve the review process

Unmet Needs Working Group: Options to Improve Program Focus Narrow priority categories Solicit proposals on specific topics Identify a focus area for interagency collaborative research Increase NVAC subcommittee roles in defining project foci and developing project proposals Issue program announcements from NVPO for focused research

Working Group Recommendations Narrow program priorities and align more closely with current HHS and NVAC priorities Obtain input from NVAC subcommittees on priority issues to address Consider multi-agency collaborative research focus for FY 08

Working Group Suggested Priority Areas for FY07 1. Vaccine financing 2. Vaccine safety For currently licensed and recommended vaccines (excluding traveler’s vaccines) 3. Adolescent vaccination (program/policy focus) 4. Public engagement on vaccine financing, safety, and adolescent vaccination 5. Improved methods for VPD detection Laboratory tests for improved diagnosis and strain typing of agents targeted by current U.S. recommended vaccines (excluding traveler’s vaccines)

FY 07 Unmet Needs Review Process Evaluation is ongoing Likely direction of changes More limited agency input on own proposals Consider agency not scoring own/other’s proposals Increase NVAC participation Adhere to standardized scoring by evaluation category Potential changes Longer technical proposal (possibly with short initial concept and development of full proposals for selected projects)

Issues for NVAC Comment on proposed priority categories for FY07 Subcommittees propose questions/issues for research within priority categories Suggest modifications to the review process Volunteer to participate in proposal reviews